Please assess the completion status of the following clinical trial:

Trial Title: Inspire® Upper Airway Stimulation System

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Meet the requirements per current CE Mark labeling~2. Willing and capable to have stimulation hardware permanently implanted, and to use the patient remote to activate the stimulation~3. Willing and capable to return for all follow-up visits and conduct sleep studies at home, including the evaluation procedures and filling out questionnaires~4. Willing and capable of providing informed consent~Exclusion Criteria:~1. Do not meet any contraindications per current CE Mark labeling~2. Body Mass Index (BMI) of \> 35~3. Central + mixed apneas \> 25% of the total apnea-hypopnea index (AHI)~4. Any chronic medical illness or condition that contraindicates a surgical procedure under general anesthesia, as judged by the clinical study Investigator~5. Has a terminal illness with life expectancy \< 12 months~6. Active psychiatric disease (psychotic illness, major depression, or acute anxiety attacks) which prevents subject compliance with the requirements of the investigational study testing~7. Any other reason the investigator deems subject is unfit for participation in the study

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Inspire® (UAS) System (Type: OTHER): This is a single-arm study; all participants will be implanted with the Inspire® Upper Airway Stimulation (UAS) System.

Based on this trial design, predict the completion outcome and termination type (if applicable).